Looking for a solid tumor meeting that helps you navigate the decisions that guide patient care?
This program brings data, experience, and differing viewpoints into one conversation. Clinicians work through the real questions behind treatment choices, and each debate tests the evidence in clear, practical ways. Q&A and case discussion reveal where certainty holds and where judgment matters, giving you takeaways that fit directly into your daily practice.
Review the comparison below to see what makes OLN Great Debates in Solid Tumors a uniquely valuable forum for clinical decision making.
OLN Great Debates in Solid Tumors is a CME-accredited oncology conference focused on real-world clinical decision-making across gastrointestinal, breast, gynecologic, lung, and genitourinary cancers.
The program is built around clinical controversies where evidence is evolving or lacks clear consensus, using case-based debates to examine different treatment strategies and how they are applied in practice.
OLN Great Debates in Solid Tumors replaces traditional lecture-based sessions with structured debates on real clinical decisions that do not have a single clear answer.
Faculty present competing approaches using clinical data and patient cases, while attendees engage through live polling, Q&A, and discussion. The format is designed to show how different experts interpret the same evidence across solid tumor care.
OLN Great Debates in Solid Tumors is designed for oncology professionals who want practical guidance on complex treatment decisions across multiple solid tumor types.
Rather than focusing on passive content delivery, the meeting emphasizes how decisions are made in real clinical scenarios, helping clinicians evaluate evidence, compare approaches, and navigate uncertainty in patient care.
Attendees gain decision-focused insights for managing complex cases across solid tumors, including:
This oncology conference is designed for healthcare professionals involved in the treatment of patients with solid tumors, including:
It is particularly relevant for clinicians managing complex or controversial treatment decisions across multiple disease areas.
Topics focus on key clinical decision points across solid tumor oncology, including:
Content spans gastrointestinal, breast, gynecologic, lung, and genitourinary cancers.
Yes. OLN Great Debates in Solid Tumors is a CME-accredited oncology conference where attendees can earn continuing medical education credits focused on clinical decision-making in solid tumors.
OLN Great Debates in Solid Tumors takes place in two U.S. locations in 2026:
OLN Great Debates in Solid Tumors is an in-person oncology conference designed to support live discussion, audience participation, networking, and real-time debate.
The agenda is developed by leading oncology experts and focuses on high-impact clinical questions across solid tumors where treatment decisions are uncertain or evolving.
Topics are selected based on emerging data, real-world clinical challenges, and areas where expert perspectives differ.
Faculty include leading medical oncologists and multidisciplinary experts across gastrointestinal, breast, gynecologic, lung, and genitourinary cancers.
Speakers are selected for both clinical expertise and their ability to evaluate and defend different treatment approaches in complex clinical scenarios.
Explore our faculty to learn more about participating experts.
OLN Great Debates in Solid Tumors is designed for oncology professionals seeking practical, case-based guidance on complex decisions across solid tumors.
The debate-driven format focuses on real clinical scenarios and competing strategies, helping clinicians understand how evidence translates into everyday patient care.
View the agenda to explore upcoming debates or register for the conference to secure your spot.
|
Key Features |
OLN Great Debates in Solid Tumors |
Compared to Other Oncology Meetings |
| Scope of Curriculum | Covers five major tumor areas (breast, lung, gastrointestinal, genitourinary, gynecologic cancers) providing a complete view of today’s solid tumor landscape. | Typically limited to one tumor type or subspecialty, reducing cross-disciplinary learning. |
| Learning Format | Built for dialogue and debate: dynamic point-counterpoint discussions, case-based exchanges, and interactive Q&A sessions that keep clinicians engaged. | Predominantly lecture-driven with limited opportunity for peer discussion or exchange of differing perspectives. |
| Faculty Depth and Engagement | Features 50+ experts who actively debate, challenge data, and connect with attendees throughout and beyond the event. | Smaller, lecture-focused faculty groups; minimal real-time engagement with participants. |
| Educational Integration | Backed by the Oncology Learning Network (OLN), which extends education year-round through articles, interviews, and case discussions. | Standalone events without sustained educational or media integration. |